Show simple item record

dc.contributor.authorPapaxoinis, Georgios
dc.contributor.authorKamposioras, K
dc.contributor.authorGermetaki, Theodora
dc.contributor.authorWeaver, Jamie M
dc.contributor.authorStamatopoulou, Sofia
dc.contributor.authorNasralla, Magdy
dc.contributor.authorKordatou, Zoe
dc.contributor.authorOwen-Holt, Vikki
dc.contributor.authorAnthoney, A
dc.contributor.authorMansoor, Was
dc.date.accessioned2018-02-12T14:11:34Z
dc.date.available2018-02-12T14:11:34Z
dc.date.issued2018-01-08
dc.identifier.citationPredictive factors of thromboembolic complications in patients with esophagogastric adenocarcinoma undergoing preoperative chemotherapy. 2018:1-9 Acta Oncolen
dc.identifier.issn1651-226X
dc.identifier.pmid29308947
dc.identifier.doi10.1080/0284186X.2017.1423375
dc.identifier.urihttp://hdl.handle.net/10541/620820
dc.description.abstractThromboembolic events (TEEs) represent a significant treatment and disease complication for cancer patients. In the present study we assessed the incidence of TEEs in patients receiving preoperative chemotherapy for esophagogastric adenocarcinoma. The risk factors for TEE development and their impact on prognosis were further analyzed.
dc.language.isoenen
dc.rightsArchived with thanks to Acta oncologica (Stockholm, Sweden)en
dc.titlePredictive factors of thromboembolic complications in patients with esophagogastric adenocarcinoma undergoing preoperative chemotherapy.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology , The Christie NHS Foundation Trust , Manchester , UKen
dc.identifier.journalActa Oncologicaen
html.description.abstractThromboembolic events (TEEs) represent a significant treatment and disease complication for cancer patients. In the present study we assessed the incidence of TEEs in patients receiving preoperative chemotherapy for esophagogastric adenocarcinoma. The risk factors for TEE development and their impact on prognosis were further analyzed.


This item appears in the following Collection(s)

Show simple item record